Healthleap Raises $38M to Help Hospitals Find Patients with Undiagnosed Conditions

Healthleap, a clinical AI platform that screens patients for conditions that often go undiagnosed, led by Josiah Meyer and Jemima Meyer, has raised $38 million in combined seed and Series A funding from Sequoia Capital, First Round Capital, and Hummingbird Ventures.

Healthleap helps care teams identify at-risk patients earlier by reviewing their complete medical records daily. The funding will support expansion into more conditions and team growth across key functions.

The Problem: Millions of Patients Leave Hospitals with Undiagnosed Conditions.

Understaffed clinical teams and manual screening leave critical conditions undetected. In malnutrition, up to half of hospitalized patients are at risk, yet fewer than 9% receive a formal diagnosis. Healthleap identifies overlooked patients, improving outcomes while helping hospitals reduce length of stay and unlock additional reimbursements. At one Penn Medicine hospital, the platform generated an estimated $23.8 million annually through incremental reimbursements and reduced hospital stays.

"Every week, millions of patients leave hospitals with unresolved health conditions that will erode their health and cost up to 10x more to treat later," explained Josiah Meyer, co-founder and CEO of Healthleap. "Finding them now is prevention, and it's a win for everyone. Patients get treated before they get sicker. Hospitals shorten stays and are paid for the care they deliver. Payers avoid the much larger cost of complications down the road. Our goal is to improve care and save lives by catching these conditions early."

How Healthleap Helps Hospitals.

Healthleap uses validated, EHR-integrated AI to continuously analyze patient records and flag risks, starting with malnutrition. Actionable risk scores help clinicians identify patients earlier, improve outcomes, reduce hospital stays, and increase reimbursements. Building on demonstrated results, the company is expanding to conditions such as heart failure, pressure ulcers, and hospital-acquired infections. The platform is HIPAA-compliant and SOC 2-certified.

"Healthleap is focused on finding patients who are being missed and getting them the care they need," said Alfred Lin, Partner at Sequoia Capital. "The impact for both patients and hospitals has been inspiring, with one hospital seeing 39% more malnutrition cases identified and treated, and $11 million in incremental revenue in a single health system."

Josh Kopelman, co-founder and partner at First Round Capital, shared, “We were immediately drawn to Healthleap's bold vision: imagine if every hospital could use real-time AI to spot overlooked clinical risk, improve patient care, and unlock meaningful reimbursement revenue. That’s exactly what Healthleap is delivering and more, starting with disease-related malnutrition and rapidly expanding across conditions to save lives and hospitals money.”